No Data
No Data
Express News | Chemours Outlook FY25 Adjusted Ebitda Between $825 Mln to $950 Mln
Express News | Chemours Outlook Q2 Net Sales to Increase in the Low to Mid-Teens Sequentially
The Chemours | 8-K: The Chemours Company Reports First Quarter 2025 Results
Chemours Cutting Qtrly Dividend by 65%
Express News | Chemours Q1 Adjusted Ebitda USD 166 Million Vs. IBES Estimate USD 171.3 Million
Express News | Chemours Q1 Sales USD 1,400 Million Vs. IBES Estimate USD 1,352 Million